![](/img/cover-not-exists.png)
Rapamycin enhances aplaviroc anti-HIV activity: Implications for the clinical development of novel CCR5 antagonists
Olga Latinovic, Alonso Heredia, Robert C. Gallo, Marv Reitz, Nhut Le, Robert R. RedfieldVolume:
83
Year:
2009
Language:
english
Pages:
4
DOI:
10.1016/j.antiviral.2009.02.199
File:
PDF, 176 KB
english, 2009